DelveInsight’s Short bowel syndrome Market Insights report provides a thorough understanding of current treatment practices, emerging Short bowel syndrome market share of the individual therapies, current and forecasted Short bowel syndrome market size from 2019 to 2032 segmented into 7MM (the USA, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).
Short Bowel Syndrome Overview
Short bowel syndrome (SBS) is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. SBS is generally broken down into individuals in whom the disorder is acquired during life and newborns in which the disorder is present at birth (congenital). Acquired short bowel syndrome is more common than the congenital form of the disorder.
Some of the key highlights of the short bowel syndrome market report
Studies conducted by Dabney et al. and Amiot et al. suggest that women are more likely to suffer from SBS as compared to men.
Acquired SBS cases are more common, whereas congenital SBS is a relatively rare condition.
In Europe the prevalence of SBS tends to be lower in regions lacking major intestinal rehabilitation centers and strong home PN/IV programs, likely due to underreporting.
Short bowel syndrome companies are included like Takeda, Zealand Pharma, VectivBio AG, 9 Meters Biopharma, and many others.
Short bowel syndrome drugs are included like Gattex (teduglutide), Glepaglutide, Apraglutide, and many others.
Short bowel syndrome Symptoms
The specific symptoms and severity of SBS vary from one person to another. Diarrhea is common, often severe and can cause dehydration, which can even be life-threatening. SBS can lead to malnutrition, unintended weight loss, and additional symptoms may be due to the loss of essential vitamins and minerals.
Short bowel syndrome Causes
In some cases, newborns can be born with a shortened bowel that is present at birth (congenital short bowel syndrome). The exact cause of a short bowel in these cases is not fully understood and several different theories have been proposed. More research is necessary to determine what factors ultimately lead to congenital short bowel syndrome.
Short bowel syndrome Treatment
The treatment of SBS is directed toward the specific symptoms that are apparent in each individual. It includes nutritional support, medications, surgery, and intestinal transplant. The specific therapeutic procedures and interventions for individuals with a short bowel syndrome might vary, depending upon numerous factors, including the specific symptoms, the site and extent of the affected portion of the small intestine, whether the colon is involved, an individual’s age and overall health, tolerance of certain medications or procedures, personal preference, and other factors.
Download Free Sample Report Now @ Short bowel syndrome Market Report
Short Bowel Syndrome Market Report Scope
The report covers the descriptive overview of Short Bowel Syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Short Bowel Syndrome epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Short Bowel Syndrome is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of the Short Bowel Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Short Bowel Syndrome market
List of Short Bowel Syndrome Companies includes-
9 Meters Biopharma, and others
List of Short Bowel Syndrome Drugs includes-
Apraglutide, and others
View Detailed Research Report Here @ https://www.delveinsight.com/sample-request/short-bowel-syndrome-market
Table of content
Competitive Intelligence Analysis
Market Overview at a Glance
Disease Background and Overview
Epidemiology and Patient Population
Treatment Algorithm, Current Treatment, and Medical Practices
Key Endpoints of Short Bowel Syndrome Treatment
Seven Major Market Analysis
7MM: Market Outlook
Access and Reimbursement Overview
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States